Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

PRP treatments for hair loss need standard protocols to be reliable.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Lavender is widely used for its calming effects and in beauty products, but its medical effectiveness is not fully proven and not FDA-approved.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Adenosine may help with hair loss, but more research is needed.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Low-level laser therapy is the most effective for hair loss, but other treatments also show promise.

Oral minoxidil is an effective alternative for hair loss but may cause more unwanted hair growth.

Six African American women experienced hair loss after switching to a new HIV medication.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Dupilumab may help regrow hair in people with severe alopecia.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Low-level laser therapy is about 80% effective in treating hair loss, with best results in males, those who use it for over a year, and those with scalp conditions like dandruff and rash.